MeSH D002100 - cachexia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002100:
Cachexia
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Megestrol | Megestrol | 1998-02-27 | |||
| Sandoz | Somatropin | Omnitrope | 2006-04-12 | |||
| Eli Lilly | Somatropin | Humatrope | 1986-10-16 | |||
| Barr Pharmaceuticals | Megestrol | Megestrol | 1995-11-30 | |||
| Strides Pharma Global | Megestrol | Megestrol | 1988-08-08 | |||
| Bristol Myers Squibb | Megestrol | Megace | 1982-01-01 | |||
| TWi Pharmaceuticals | Megestrol | Megestrol | 2014-08-27 | |||
| Hikma Pharmaceuticals | Megestrol | Megestrol | 1995-09-29 | |||
| Pharmacia & Upjohn | Somatropin | Genotropin | 1995-08-24 | |||
| Genentech | Somatropin | Nutropin | 1993-11-17 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
20%2/10
Phase 2
10%1/10
Phase 3
21%3/14
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use